Alivus Life Sciences Ltd.

The quarter ended June 2025 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 6018.46 millions.The Company has registered profit of Rs. 1215.35  millions for the quarter ended June 2025, a growth of 9.02%  over Rs. 1114.83 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended June 2025 rose to 1812.96 millions as compared to 1649.78 millions of corresponding quarter ended June 2024.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	6018.46	5886.16	2.25	6018.46	5886.16	2.25	23868.84	22832.14	4.54
Other Income	89.85	54.93	63.57	89.85	54.93	63.57	345.70	120.42	187.08
PBIDT	1812.96	1649.78	9.89	1812.96	1649.78	9.89	7171.54	6862.88	4.50
Interest	12.51	3.53	254.39	12.51	3.53	254.39	24.14	15.46	56.14
PBDT	1800.45	1646.25	9.37	1800.45	1646.25	9.37	7147.40	6847.42	4.38
Depreciation	170.64	143.87	18.61	170.64	143.87	18.61	606.09	534.52	13.39
PBT	1629.81	1502.38	8.48	1629.81	1502.38	8.48	6541.31	6312.90	3.62
TAX	414.46	387.55	6.94	414.46	387.55	6.94	1685.04	1604.02	5.05
Deferred Tax	25.10	12.38	102.75	25.10	12.38	102.75	60.64	81.88	-25.94
PAT	1215.35	1114.83	9.02	1215.35	1114.83	9.02	4856.27	4708.88	3.13
Equity	245.26	245.05	0.09	245.26	245.05	0.09	245.07	245.05	0.01
PBIDTM(%)	30.12	28.03	7.48	30.12	28.03	7.48	30.05	30.06	-0.04